Brief: Enveric Biosciences Announces Signing Of Non-Binding Term Sheet With Undisclosed Licensee For Exclusive License To Patented Methods Of Treating Breast And Other Cancers Using Cannabinoids
08/05/2024 12:22
May 8 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES ANNOUNCES SIGNING OF NON-BINDING TERM
SHEET
WITH UNDISCLOSED LICENSEE FOR EXCLUSIVE LICENSE TO PATENTED
METHODS OF TREATING BREAST AND OTHER CANCERS USING CANNABINOIDS
* ENVERIC BIOSCIENCES INC - LICENSEE WILL PAY CO LICENSE
EXECUTION
FEE,DEVELOPMENT, SALES MILESTONES UP TO $61 MILLION, AND
ROYALTIES ON ALL FUTURE SALES
* ENVERIC BIOSCIENCES INC - LICENSEE ALSO HAS A CASH BUYOUT
OPTION
Source text for Eikon: ID:nBw32Q5Xja
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003